Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.50p
   
  • Change Today:
    -0.25p
  • 52 Week High: 12.10
  • 52 Week Low: 4.50
  • Currency: UK Pounds
  • Shares Issued: 6,332m
  • Volume: 164,828
  • Market Cap: £284.96m
  • RiskGrade: 268
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
24.49% below the market average24.49% below the market average24.49% below the market average24.49% below the market average24.49% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
26.86% above the market average26.86% above the market average26.86% above the market average26.86% above the market average26.86% above the market average
5.26% above the sector average5.26% above the sector average5.26% above the sector average5.26% above the sector average5.26% above the sector average
Price Book Ratio Not Available

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
19.14% above the market average19.14% above the market average19.14% above the market average19.14% above the market average19.14% above the market average
34.88% above the sector average34.88% above the sector average34.88% above the sector average34.88% above the sector average34.88% above the sector average
Price Chg 3m
68.35% above the market average68.35% above the market average68.35% above the market average68.35% above the market average68.35% above the market average
72.09% above the sector average72.09% above the sector average72.09% above the sector average72.09% above the sector average72.09% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI Not Available
Momentum 20 Not Available

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
73.69% below the market average73.69% below the market average73.69% below the market average73.69% below the market average73.69% below the market average
3.70% above the sector average3.70% above the sector average3.70% above the sector average3.70% above the sector average3.70% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
54.2% below the market average54.2% below the market average54.2% below the market average54.2% below the market average54.2% below the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
0.83% above the market average0.83% above the market average0.83% above the market average0.83% above the market average0.83% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Operating Profit Loss
91.14% below the market average91.14% below the market average91.14% below the market average91.14% below the market average91.14% below the market average
74.36% below the sector average74.36% below the sector average74.36% below the sector average74.36% below the sector average74.36% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
3.04% above the market average3.04% above the market average3.04% above the market average3.04% above the market average3.04% above the market average
45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average
Cash
9.69% above the market average9.69% above the market average9.69% above the market average9.69% above the market average9.69% above the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
10.48% above the market average10.48% above the market average10.48% above the market average10.48% above the market average10.48% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 4.50p
Change Today -0.25p
% Change -5.26 %
52 Week High 12.10
52 Week Low 4.50
Volume 164,828
Shares Issued 6,332m
Market Cap £284.96m
Beta 0.00
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
4.2% below the market average4.2% below the market average4.2% below the market average4.2% below the market average4.2% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
Price Trend
89.34% above the market average89.34% above the market average89.34% above the market average89.34% above the market average89.34% above the market average
81.40% above the sector average81.40% above the sector average81.40% above the sector average81.40% above the sector average81.40% above the sector average
Income Not Available
Growth
33.61% below the market average33.61% below the market average33.61% below the market average33.61% below the market average33.61% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AGY Dividends

No dividends found

Trades for 16-Oct-2026

Time Volume / Share Price
12:35 75,000 @ 4.50p
12:31 10,000 @ 4.60p
12:26 52,933 @ 4.51p
12:26 20 @ 5.00p
12:26 80 @ 5.00p

AGY Key Personnel

CEO Manuel Llobet

Top of Page